Dr. Jianpeng Sheng currently holds a distinguished position as a Professor at Zhejiang University's esteemed Cancer Center. Initiating his intellectual journey in 2005, he was the recipient of a prestigious Singapore Government Scholarship which led him to Nanyang Technological University. There, he distinguished himself by graduating with Honors in 2009, earning a Bachelor of Science degree. In 2010, he ventured into the specialized field of immunology, guided by the eminent Prof. Klaus Karjalainen. His pursuit of knowledge culminated in a PhD in 2014, marking the beginning of his extensive contributions to immunological research. Following his doctoral studies, he served as a research fellow in the Immunology Laboratory, expanding his expertise and honing his investigative skills. In 2019, he ascended to the role of Principal Investigator at Zhejiang University, a testament to his leadership and research abilities. His significant scholarly output includes the publication of 44 articles in Science Citation Index (SCI) journals, with 15 of these featured in high-impact-factor publications. His research interests traverse a broad spectrum, encompassing Immunology, Tumor Immunology, Single Cell Histology, Single Cell In Situ Imaging, Cell Lineage Tracking, Precision Therapy, and Protein Drug Development. These diverse areas of focus reflect his commitment to integrating multi-omics and spatial multi-omics into the study and treatment of cancer.
Dr. Jianpeng Sheng currently holds a distinguished position as a Professor at Zhejiang University's esteemed Cancer Center. Initiating his intellectual journey in 2005, he was the recipient of a prestigious Singapore Government Scholarship which led him to Nanyang Technological University. There, he distinguished himself by graduating with Honors in 2009, earning a Bachelor of Science degree. In 2010, he ventured into the specialized field of immunology, guided by the eminent Prof. Klaus Karjalainen. His pursuit of knowledge culminated in a PhD in 2014, marking the beginning of his extensive contributions to immunological research. Following his doctoral studies, he served as a research fellow in the Immunology Laboratory, expanding his expertise and honing his investigative skills. In 2019, he ascended to the role of Principal Investigator at Zhejiang University, a testament to his leadership and research abilities. His significant scholarly output includes the publication of 44 articles in Science Citation Index (SCI) journals, with 15 of these featured in high-impact-factor publications. His research interests traverse a broad spectrum, encompassing Immunology, Tumor Immunology, Single Cell Histology, Single Cell In Situ Imaging, Cell Lineage Tracking, Precision Therapy, and Protein Drug Development. These diverse areas of focus reflect his commitment to integrating multi-omics and spatial multi-omics into the study and treatment of cancer.